Noom

Noom

Behavior change platform for weight loss

About Noom

Simplify's Rating
Why Noom is rated
B-
Rated C on Competitive Edge
Rated B on Growth Potential
Rated B on Rating Differentiation

Industries

AI & Machine Learning

Healthcare

Company Size

1,001-5,000

Company Stage

Series F

Total Funding

$650M

Headquarters

New York City, New York

Founded

2008

Overview

Noom focuses on helping individuals change their behaviors related to weight loss and health. The platform combines artificial intelligence, mobile technology, and psychological principles to provide personalized coaching and support. Users engage with behavior change courses and a virtual diabetes prevention program that has received recognition from the CDC. Unlike many competitors, Noom emphasizes a holistic approach that integrates mental and emotional aspects of health, making it more than just a diet plan. The goal of Noom is to improve health outcomes for users by fostering sustainable lifestyle changes.

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for AI-driven health platforms boosts Noom's market potential.
  • Telehealth expansion allows Noom to enhance virtual coaching services.
  • Rising chronic diseases increase demand for Noom's preventive health programs.

What critics are saying

  • Increased competition from similar digital health platforms threatens Noom's market share.
  • Regulatory scrutiny may delay Noom's oral medication product rollouts.
  • Data privacy concerns arise from Noom's reliance on AI and body scan technology.

What makes Noom unique

  • Noom integrates AI, psychology, and coaching for personalized health solutions.
  • The platform offers a CDC-recognized virtual diabetes prevention program.
  • Noom's body scan tech provides detailed body composition stats via smartphone.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$650M

Above

Industry Average

Funded Over

7 Rounds

Notable Investors:
Series F funding comparison data is currently unavailable. We're working to provide this information soon!
Series F Funding Comparison
Coming Soon

Benefits

Health Insurance

401(k) Retirement Plan

Paid Holidays

Paid Vacation

Disability Insurance

Wellness Program

Professional Development Budget

Hybrid Work Options

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

1%

2 year growth

1%
The Female Body
Jan 13th, 2025
Noom Expands Weight Loss Solutions with Metformin Program

Noom, the digital healthcare company renowned for its science-backed approach to behaviour change, has launched a new program integrating oral medications into its Noom Med offerings.

Athletech News
Dec 13th, 2024
Noom Adds $29 Oral Weight Loss Med Dubbed a "Miracle Drug"

More recently, Noom created a GLP-1 Supply Tracker and unveiled high-protein meal replacement bars and shakes for those on weight loss medication users.

Athletech News
Oct 23rd, 2024
Noom Adds Body Scan Tech for GLP-1 Users

Last year, Cook was named Noom's CEO as the platform began its push into the weight loss medication space.

Morningstar
Oct 21st, 2024
Noom Unveils Two New Enterprise Products to Help Employers Offer, Manage, and Effectively Control GLP-1 Expenses

Noom partnered with Waltz Health to provide direct, cost-effective access to GLP-1 medications, bypassing traditional intermediaries and reducing overall treatment costs for employers.

Trend Hunter
Oct 21st, 2024
Medication Cost Management Platforms

Noom has launched two new enterprise solutions aimed at assisting employers with managing GLP-1 medication costs while promoting effective obesity management.

Recently Posted Jobs

Sign up to get curated job recommendations

Noom is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Noom's jobs every few hours, so check again soon! Browse all jobs →